Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 TTOO | Healthcare | $0.01 | 13.91K | $252.41K | 0.00 | ― | ― |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| TTOO | T2 Biosystems | 0.01 | -0.00 | -16.67% |
| Name | Price | % Change | |
|---|---|---|---|
| TTOO | $0.01 | -16.67% |
New option listings for January 20th include Telefonica S.A. (TELFY). Option delistings effective January 20th include MSCI USA Gross Total Return USD Index (.MXUSA), MSCI World Net Total Return USD
T2 Biosystems ( ($TTOO) ) has released a notification of late filing. T2 Biosystems, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period
T2 Biosystems ( ($TTOO) ) has provided an announcement. On February 13, 2025, T2 Biosystems’ Board of Directors approved a significant reduction-in-force affecting nearly all employees, resulting in expected one-time
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Paychex (PAYX) agreed to acquire Paycor HCM (PYCR) for
“We made considerable progress across the business during 2024, increasing our global installed base of T2Dx Instruments, and generating record sales for our sepsis test panels, including record U.S. sales
T2 Biosystems ( ($TTOO) ) has provided an update. T2 Biosystems, Inc. held its annual meeting of stockholders, where key corporate governance matters were addressed, including the approval of an
T2 Biosystems (TTOO) announced the sale of four T2Dx Instruments to its European distributor that represents multiple EU counties, demonstrating commercial expansion and increased international market penetration. The multiple instrument
T2 Biosystems (TTOO) announced that it has surpassed the shipment of 250,000 sepsis tests, marking a significant milestone that underscores the growing customer adoption of the Company’s direct-from-whole-blood technology. A
T2 Biosystems (TTOO) announced that its multi-year capital equipment supplier agreement with Vizient has been extended through March 31, 2026. The products covered under the contract with Vizient include the
T2 Biosystems ( ($TTOO) ) has issued an update. T2 Biosystems is set to expand its market leadership by licensing its cutting-edge technology for detecting sepsis-causing pathogens directly from whole
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
